Physician profile
Stephen E Haring
NPI 1164575395
$6,362.06
in general payments reported to CMS, 2019-2025
24 companies · $598 in 2025
The $598 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,137 · 2020: $555 · 2021: $1,007 · 2022: $1,342 · 2023: $891 · 2024: $832 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,320.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,253.87 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,128.65 | 2019-2025 | Precision7, Total30, Precision 1 |
| Bausch & Lomb Americas INC. | $733.60 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Coopervision INC. | $462.45 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Onefit Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $395.04 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $343.03 | 2019-2022 | |
| Glaukos Corporation | $341.88 | 2022-2025 | Idosetr |
| Carl Zeiss Meditec, INC. | $311.46 | 2019-2020 | |
| Allergan, INC. | $257.93 | 2019-2020 | |
| Oyster Point Pharma, INC. | $146.98 | 2022 | |
| Abbvie INC. | $136.34 | 2022-2023 | |
| Lombart Brothers, INC. | $125.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $119.05 | 2021 | |
| Dompe US, INC. | $106.31 | 2021-2024 | Oxervate |
| Synergeyes, INC. | $93.00 | 2019-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Staar Surgical Company | $88.71 | 2019 | |
| Heru, INC. | $70.03 | 2022 | |
| Sight Sciences, INC. | $59.04 | 2022 | |
| Abb Con-Cise Optical Group LLC | $58.38 | 2019-2021 | |
| Lkc Technologies, INC. | $47.26 | 2024-2025 | |
| Topcon Healthcare, INC. | $24.42 | 2022 | |
| Menicon America INC | $20.13 | 2019 | |
| Biotissue Holdings INC. | $20.10 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Haring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.